Seaport Therapeutics is a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric medicines with a proven strategy and team.
Market
Neuropsychiatric medicines
Location
Boston,
MA,
USA
Coinvestors
General Atlantic, T. Rowe Price Associates, Inc., Foresite Capital, Invus, Goldman Sachs Alternatives, CPP Investments, ARCH Venture Partners, Sofinnova Investments, Third Rock Ventures, PureTech Health